ACCREDITATION STATUS:

UKAS accredited - Proficiency testing provider No. 7804

This programme is operated by UK NEQAS Leucocyte Immunophenotyping. The centre provides flow cytometry and molecular haematology based programmes. For further information on the operation of the programme or details on current accreditation status please contact UK NEQAS Leucocyte Immunophenotyping directly.

Email: admin@ukneqasli.co.uk

Telephone: +44 (0) 114 267 3600

CLINICAL APPLICATION:

Diagnosis of leukaemia

PURPOSE OF PROGRAMME:

This programme is designed to assess a laboratory's ability to diagnose leukaemia using a full spectrum of laboratory tests.

ANALYTES:

Analyte	Default Unit
a detailed case history	Lineage, differentiation and diagnosis based on the WHO guidelines
a digitally scanned blood smear for morphological analysis	Lineage, differentiation and diagnosis based on the WHO guidelines
a full consensus phenotype (derived from the corresponding part one exercise)	Lineage, differentiation and diagnosis based on the WHO guidelines
cytogenetics	Lineage, differentiation and diagnosis based on the WHO guidelines
molecular genetics data and histology data if available	Lineage, differentiation and diagnosis based on the WHO guidelines

PROGRAMME OF ANALYSIS:

Results are entered online via the UK NEQAS LI website. Trials are live for 3 weeks. Results can be entered at any time during this period. Under exceptional circumstances late results are accepted at our discretion via email/fax.

DATA ANALYSIS:

Qualitative analysis based on the consensus diagnosis submitted by participants

PERFORMANCE MONITORING:

Participant performance is not monitored at this time

PERSISTENT POOR PERFORMANCE:

Participant performance is not monitored at this time